Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High prevalence of long-term psychophysical olfactory dysfunction in patients with COVID-19

View ORCID ProfilePaolo Boscolo-Rizzo, Anna Menegaldo, Cristoforo Fabbris, Giacomo Spinato, Daniele Borsetto, Luigi Angelo Vaira, Leonardo Calvanese, Andrea Pettorelli, Massimo Sonego, Daniele Frezza, Andy Bertolin, Walter Cestaro, Roberto Rigoli, Giancarlo Tirelli, Maria Cristina Da Mosto, Anna Menini, Jerry Polesel, Claire Hopkins
doi: https://doi.org/10.1101/2021.01.07.21249406
Paolo Boscolo-Rizzo
1Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paolo Boscolo-Rizzo
Anna Menegaldo
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristoforo Fabbris
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cristoforo.fabbris@gmail.com
Giacomo Spinato
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniele Borsetto
3Department of ENT, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Angelo Vaira
4Unit of Maxillofacial Surgery, Sassari University Hospital, Sassari, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Calvanese
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Pettorelli
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Sonego
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniele Frezza
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Bertolin
5Unit of Otolaryngology, AULSS 2 - Marca Trevigiana, Vittorio Veneto, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Cestaro
6Unit of Otolaryngology, AULSS 2 - Marca Trevigiana, Montebelluna, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Rigoli
7Department of Clinical Pathology, AULSS 2 - Marca Trevigiana, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giancarlo Tirelli
1Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Cristina Da Mosto
2Department of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Menini
8Neurobiology Group, SISSA, Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Polesel
9Unit of Cancer Epidemiology, Aviano National Cancer Institute, IRCCS, Aviano, Italy
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Hopkins
10Guy’s and St Thomas’ Hospitals, London, United Kingdom
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

This study prospectively assessed the long-term prevalence of self-reported and psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID-19. Self-reported smell or taste impairment was prospectively evaluated by SNOT-22 at diagnosis, 4-week, 8-week, and 6-month. At 6 months from the diagnosis, psychophysical evaluation of olfactory function was also performed using the 34-item culturally adapted University of Pennsylvania Smell Identification Test (CA-UPSIT). 145 completed both the 6-month subjective and psychophysical olfactory evaluation. According to CA-UPSIT, 87 subjects (60.0%) exhibited some smell dysfunction, with 54 (37.2) being mildly microsmic, 16 (11.0%) moderately microsmic, 7 (4.8%) severely microsmic, and 10 patients (6.9%) being anosmic. At the time CA-UPSIT was administered, a weak correlation was observed between the self-reported alteration of sense of smell or taste and olfactory test scores (Spearman’s r=-0.26). Among 112 patients who self-reported normal sense of smell at last follow-up, CA-UPSIT revealed normal smell in 46 (41.1%), mild microsmia in 46 (41.1%), moderate microsmia in 11 (9.8%), severe microsmia in 3 (2.3%), and anosmia in 6 (5.4%) patients; however, of those patients self-reporting normal smell but who were found to have hypofunction on testing, 62 out of 66 had self-reported reduction in sense of smell or taste at an earlier time point. Despite most patients report a subjectively normal sense of smell, we observed a high percentage of persistent smell dysfunction at 6 months from the diagnosis of SARS-CoV-2 infection, with 11.7% of patients being anosmic or severely microsmic. These data highlight a significant long-term rate of smell alteration in patients with previous SARS-CoV-2 infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted with the approval of the ethic committee for clinical experimentation of Treviso and Belluno provinces (ethic vote: 780/CE).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data are within the paper and its Supporting Information files.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High prevalence of long-term psychophysical olfactory dysfunction in patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High prevalence of long-term psychophysical olfactory dysfunction in patients with COVID-19
Paolo Boscolo-Rizzo, Anna Menegaldo, Cristoforo Fabbris, Giacomo Spinato, Daniele Borsetto, Luigi Angelo Vaira, Leonardo Calvanese, Andrea Pettorelli, Massimo Sonego, Daniele Frezza, Andy Bertolin, Walter Cestaro, Roberto Rigoli, Giancarlo Tirelli, Maria Cristina Da Mosto, Anna Menini, Jerry Polesel, Claire Hopkins
medRxiv 2021.01.07.21249406; doi: https://doi.org/10.1101/2021.01.07.21249406
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
High prevalence of long-term psychophysical olfactory dysfunction in patients with COVID-19
Paolo Boscolo-Rizzo, Anna Menegaldo, Cristoforo Fabbris, Giacomo Spinato, Daniele Borsetto, Luigi Angelo Vaira, Leonardo Calvanese, Andrea Pettorelli, Massimo Sonego, Daniele Frezza, Andy Bertolin, Walter Cestaro, Roberto Rigoli, Giancarlo Tirelli, Maria Cristina Da Mosto, Anna Menini, Jerry Polesel, Claire Hopkins
medRxiv 2021.01.07.21249406; doi: https://doi.org/10.1101/2021.01.07.21249406

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)